213Bi-MELANIN

N/A

Report date: 2025/11/14 09:32:46

Base Information

Drug Name213Bi-MELANIN

Drug Alias Name213Bismuth-melanin

ClassificationRadiation-emitting products > Nuclides > Bismuth > 213BiRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Radionuclide Drug Conjugates +[4]

Mechanisms of ActionAnti-melanin

TargetsMelanin

Therapy Area/IndicationsMelanoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesRadimmune Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesRadimmune Therapeutics Inc

Inactive CompaniesN/A

Active IndicationsMelanoma

Inactive IndicationsN/A

Other Information

ATC CodeN/A